Academic Journal
Enzymatic synthesis of antibody-human serum albumin conjugate for targeted drug delivery using tyrosinase from Agaricus bisporus
| العنوان: | Enzymatic synthesis of antibody-human serum albumin conjugate for targeted drug delivery using tyrosinase from Agaricus bisporus |
|---|---|
| المؤلفون: | Rollett, Alexandra, Thallinger, Barbara, Ohradanova-Repic, Anna, Machacek, Christian, Walenta, Evelyn, Paulo, Artur Cavaco, Birner-Gruenberger, Ruth, Bogner-Strauss, Juliane G., Stockinger, Hannes, Guebitz, G. M. |
| بيانات النشر: | Royal Society of Chemistry The Royal Society of Chemistry |
| سنة النشر: | 2013 |
| المجموعة: | Universidade of Minho: RepositóriUM |
| مصطلحات موضوعية: | Science & Technology |
| الوصف: | Highly specific targeted drug delivery devices can be obtained with antibody-human serum albumin (mAb-HSA) conjugates. However, their conventional production involves several reaction steps including chemical modification and activation of both proteins followed by cross-linking often involving toxic chemicals. Here, we describe the enzymatic synthesis of mAb-HSA conjugates for targeted drug delivery devices using tyrosinase from Agaricus bisporus under mild reaction conditions (pH 6.8, 25 [degree]C). Reaction conditions were optimized by using fluorescence labeled HSA to facilitate SDS-PAGE analysis with fluorescence scanning. Enzymatic cross-linking in the presence of natural low molecular weight phenolic compounds (e.g. caffeic acid) resulted in reaction products in the molecular weight range of [similar]216 kDa, corresponding to mAb-HSA conjugates. The composition of the conjugates was confirmed with tryptic digestion followed by LC-MS/MS analysis of the resulting peptide fragments. Successful binding of mAb-HSA conjugates (in contrast to free HSA) to MHC II molecules, located on antigen-presenting cells, was demonstrated by both ELISA and flow cytometry analysis. ; This work has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement NMP4-LA-2009-228827 NANOFOL and FWF, DK: Metabolic and Cardiovascular Disease: W1226-B18. We thank Tamara Reiter, Graz University of Technology for technical support with SEC; Exbio from the Czech Republic for providing the mAbs and Britta Obrist, Medical University of Graz and the Austrian Centre of Industrial Biotechnology, for technical assistance with LC-MS/MS analysis. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 2046-2069 |
| Relation: | http://hdl.handle.net/1822/27462 |
| DOI: | 10.1039/c2ra22560c |
| الاتاحة: | http://hdl.handle.net/1822/27462 https://doi.org/10.1039/c2ra22560c |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.4DD40222 |
| قاعدة البيانات: | BASE |
| تدمد: | 20462069 |
|---|---|
| DOI: | 10.1039/c2ra22560c |